Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100T3FG
Period2023-01-01 → 2023-12-31
Filed2024-03-22
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Key figures · 114
MetricValuePeriodScopeSource row
Revenue¥5.6bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥10.0bn2022-01-01 → 2022-12-31Cons.Net sales
Operating income−¥812m2023-01-01 → 2023-12-31Cons.Operating income
Operating income¥2.0bn2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income−¥736m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss
Net income¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥8.2bnat 2023-12-31Cons.Assets
Total assets¥10.4bnat 2022-12-31Cons.Assets
Total liabilities¥960mat 2023-12-31Cons.Liabilities
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥7.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2021-12-31dCons.Net assets
Cash and deposits¥6.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥6.3bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow−¥195m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥377m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥680m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥628m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.192023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.22022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥164.32at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥204.83at 2022-12-31Cons.Net assets per share (5-year summary)
Equity ratio84.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
Employees109at 2023-12-31Cons.Number of employees
Employees122at 2022-12-31Cons.Number of employees
Revenue¥5.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥10.0bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥8.3bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.8bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥852m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥2.0bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥774m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥1.0bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥2.0bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥2.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥8.2bnat 2023-12-31StandaloneAssets
Total assets¥10.4bnat 2022-12-31StandaloneAssets
Total assets¥8.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥980mat 2023-12-31StandaloneLiabilities
Total liabilities¥1.9bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥7.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥8.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥6.3bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.9bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.7bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-49.792023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-189.032019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥164.02at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥204.95at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥143.07at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio84.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued42,278,081at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,603,606at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,437,681at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees103at 2023-12-31StandaloneNumber of employees
Employees118at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2023-12-31109 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,272
ItemContextValueUnit
Commission fee ope cfCurrentYearDuration12728000JPY
Stock issuance cost ope cfPrior1YearDuration45867000JPY
Stock issuance cost ope cfCurrentYearDuration11478000JPY
Gain on reversal of subscription rights to shares ope cfPrior1YearDuration-106401000JPY
Gain on reversal of subscription rights to shares ope cfCurrentYearDuration-101333000JPY
Loss on retirement of noncurrent assets ope cfPrior1YearDuration540000JPY
Loss on retirement of noncurrent assets ope cfCurrentYearDuration7868000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YearDuration62594000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYearDuration1171821000JPY
Decrease increase in inventories ope cfPrior1YearDuration-82746000JPY
Decrease increase in inventories ope cfCurrentYearDuration237277000JPY
Decrease increase in prepaid expenses ope cfPrior1YearDuration-64874000JPY
Decrease increase in prepaid expenses ope cfCurrentYearDuration90614000JPY
Decrease increase in consumption taxes receivable payable ope cfPrior1YearDuration-270711000JPY
Decrease increase in consumption taxes receivable payable ope cfCurrentYearDuration-212814000JPY
Decrease increase in other current assets ope cfPrior1YearDuration-89984000JPY
Decrease increase in other current assets ope cfCurrentYearDuration-23384000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YearDuration-23050000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYearDuration-46633000JPY
Increase decrease in accounts payable other ope cfPrior1YearDuration685306000JPY
Increase decrease in accounts payable other ope cfCurrentYearDuration-310273000JPY
Increase decrease in other current liabilities ope cfPrior1YearDuration-105844000JPY
Increase decrease in other current liabilities ope cfCurrentYearDuration-66344000JPY
Other net ope cfPrior1YearDuration157769000JPY
Other net ope cfCurrentYearDuration-1700000JPY
Subtotal ope cfPrior1YearDuration2034463000JPY
Subtotal ope cfCurrentYearDuration171781000JPY
Interest and dividends income received ope cf inv cfPrior1YearDuration98000JPY
Interest and dividends income received ope cf inv cfCurrentYearDuration274000JPY
Commitment fee paid ope cfPrior1YearDuration-56543000JPY
Commitment fee paid ope cfCurrentYearDuration-12029000JPY
Income taxes paid ope cfPrior1YearDuration-363776000JPY
Income taxes paid ope cfCurrentYearDuration-354711000JPY
Net cash provided by used in operating activitiesPrior1YearDuration1614241000JPY
Net cash provided by used in operating activitiesCurrentYearDuration-194685000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration-2034000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration-204250000JPY
Purchase of intangible assets inv cfPrior1YearDuration-45524000JPY
Purchase of intangible assets inv cfCurrentYearDuration-28547000JPY
Payments for lease and guarantee deposits inv cfPrior1YearDuration－JPY
Payments for lease and guarantee deposits inv cfCurrentYearDuration-143898000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YearDuration432000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYearDuration－JPY
Net cash provided by used in investment activitiesPrior1YearDuration-47127000JPY
Net cash provided by used in investment activitiesCurrentYearDuration-376696000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YearDuration146000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYearDuration274000JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YearDuration13760000JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYearDuration－JPY
Payments for issuance of common stock fin cfPrior1YearDuration-45837000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass